Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis.

Sciammas R, Kodukula P, Tang Q, Hendricks RL, Bluestone JA.

J Exp Med. 1997 Jun 2;185(11):1969-75.

5.

Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure.

Parker ZM, Pasieka TJ, Parker GA, Leib DA.

J Virol. 2016 Nov 14;90(23):10789-10799. doi: 10.1128/JVI.01473-16. Print 2016 Dec 1.

6.

CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.

Srivastava R, Khan AA, Chilukuri S, Syed SA, Tran TT, Furness J, Bahraoui E, BenMohamed L.

J Virol. 2017 Jun 26;91(14). pii: e00278-17. doi: 10.1128/JVI.00278-17. Print 2017 Jul 15.

8.

A murine CD4-, CD8- T cell receptor-gamma delta T lymphocyte clone specific for herpes simplex virus glycoprotein I.

Johnson RM, Lancki DW, Sperling AI, Dick RF, Spear PG, Fitch FW, Bluestone JA.

J Immunol. 1992 Feb 15;148(4):983-8.

PMID:
1310711
9.

Evidence that deficient IFN-gamma production is a biological basis of herpes simplex virus type-2 neurovirulence.

Lewandowski G, Hobbs M, Geller A.

J Neuroimmunol. 1998 Jan;81(1-2):66-75.

PMID:
9521607
10.

Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.

Davido DJ, Tu EM, Wang H, Korom M, Gazquez Casals A, Reddy PJ, Mostafa HH, Combs B, Haenchen SD, Morrison LA.

J Virol. 2018 Aug 16;92(17). pii: e01036-18. doi: 10.1128/JVI.01036-18. Print 2018 Sep 1.

11.

Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.

Srivastava R, Khan AA, Garg S, Syed SA, Furness JN, Vahed H, Pham T, Yu HT, Nesburn AB, BenMohamed L.

J Virol. 2017 Jan 3;91(2). pii: e01793-16. doi: 10.1128/JVI.01793-16. Print 2017 Jan 15.

12.
13.
14.

HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes.

Maccario R, Revello MG, Comoli P, Montagna D, Locatelli F, Gerna G.

J Immunol. 1993 Feb 15;150(4):1437-45.

PMID:
8381835
15.

Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system.

Kodukula P, Liu T, Rooijen NV, Jager MJ, Hendricks RL.

J Immunol. 1999 Mar 1;162(5):2895-905.

16.

Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection.

Minami M, Kita M, Yan XQ, Yamamoto T, Iida T, Sekikawa K, Iwakura Y, Imanishi J.

J Interferon Cytokine Res. 2002 Jun;22(6):671-6.

PMID:
12162877
17.

ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.

Halford WP, Weisend C, Grace J, Soboleski M, Carr DJ, Balliet JW, Imai Y, Margolis TP, Gebhardt BM.

Virol J. 2006 Jun 9;3:44.

18.

Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice.

St Leger AJ, Peters B, Sidney J, Sette A, Hendricks RL.

J Immunol. 2011 Apr 1;186(7):3927-33. doi: 10.4049/jimmunol.1003735. Epub 2011 Feb 25.

19.

Immunity to rotavirus in T cell deficient mice.

Franco MA, Greenberg HB.

Virology. 1997 Nov 24;238(2):169-79.

20.

The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity.

Mott KR, Chentoufi AA, Carpenter D, BenMohamed L, Wechsler SL, Ghiasi H.

Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2903-12. doi: 10.1167/iovs.08-2957. Epub 2009 Jan 24.

PMID:
19168902

Supplemental Content

Support Center